{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:03:51Z","timestamp":1790039031993,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ajpc.2026.101717","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T15:46:49Z","timestamp":1782748009000},"page":"101717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effects of PCSK9 inhibitors on coronary atheroma morphology in patients with coronary artery disease treated with statins: a meta-analysis and systematic review"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9881-3541","authenticated-orcid":false,"given":"Priyesh","family":"Thakurathi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Nanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khagendra","family":"Dahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva S.","family":"Aryal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quinn","family":"Pack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh K.","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond G.","family":"McKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Goldsweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ajpc.2026.101717_bib0001","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/jama.2022.12138","article-title":"Statin use for the primary prevention of cardiovascular disease in adults: updated evidence report and systematic review for the US preventive services task force","volume":"328","author":"Chou","year":"2022","journal-title":"JAMA"},{"issue":"10059","key":"10.1016\/j.ajpc.2026.101717_bib0002","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","article-title":"Interpretation of the evidence for the efficacy and safety of statin therapy","volume":"388","author":"Collins","year":"2016","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ajpc.2026.101717_bib0003","first-page":"e596","article-title":"2019 ACC\/AHA Guideline on the primary prevention of cardiovascular disease: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"32","key":"10.1016\/j.ajpc.2026.101717_bib0004","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European atherosclerosis society consensus panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"issue":"25","key":"10.1016\/j.ajpc.2026.101717_bib0005","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.ajpc.2026.101717_bib0006","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1016\/j.jacc.2015.05.001","article-title":"Are PCSK9 inhibitors the next breakthrough in the cardiovascular field?","volume":"65","author":"Giugliano","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.ajpc.2026.101717_bib0007","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.ajpc.2026.101717_bib0008","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.ajpc.2026.101717_bib0009","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1316222","article-title":"A 52-week placebo-controlled trial of evolocumab in hyperlipidemia","volume":"370","author":"Blom","year":"2014","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ajpc.2026.101717_bib0010","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/eurheartj\/ehu373","article-title":"Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study","volume":"36","author":"R\u00e4ber","year":"2015","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1016\/j.ajpc.2026.101717_bib0011","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1110874","article-title":"Effect of two intensive statin regimens on progression of coronary disease","volume":"365","author":"Nicholls","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ajpc.2026.101717_bib0012","first-page":"336","article-title":"Focused update of expert consensus statement: Use of invasive assessments of coronary physiology and structure: a position statement of the society of cardiac angiography and interventions","volume":"92","author":"Lotfi","year":"2018","journal-title":"Catheter Cardiovasc Interv: Off J Soc Card Angiogr Interv"},{"key":"10.1016\/j.ajpc.2026.101717_bib0013","series-title":"Cochrane handbook for systematic reviews of interventions version 6.5 (updated August 2024)","year":"2024"},{"key":"10.1016\/j.ajpc.2026.101717_bib0014","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ajpc.2026.101717_bib0015","unstructured":"Review manager (RevMan) [Computer program]. Version 5.4. Copenhagen: the cochrane collaboration, 2020."},{"key":"10.1016\/j.ajpc.2026.101717_bib0016","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"22","key":"10.1016\/j.ajpc.2026.101717_bib0017","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1001\/jama.2016.16951","article-title":"Effect of evolocumab on progression of coronary disease in statin-treated patients: The GLAGOV randomized clinical trial","volume":"316","author":"Nicholls","year":"2016","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.ajpc.2026.101717_bib0018","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1253\/circj.CJ-19-0412","article-title":"Effect of alirocumab on coronary atheroma volume in japanese patients with acute coronary syndrome - The ODYSSEY J-IVUS Trial","volume":"83","author":"Ako","year":"2019","journal-title":"Circ J: Off J Jpn Circ Soc"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101717_bib0019","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12944-021-01528-3","article-title":"Effect of alirocumab on coronary plaque in patients with coronary artery disease assessed by optical coherence tomography","volume":"20","author":"Gao","year":"2021","journal-title":"Lipids Health Dis"},{"issue":"18","key":"10.1016\/j.ajpc.2026.101717_bib0020","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1001\/jama.2022.5218","article-title":"Effect of alirocumab added to high-intensity statin therapy on coronary atherosclerosis in patients with acute myocardial infarction: the PACMAN-AMI randomized clinical trial","volume":"327","author":"R\u00e4ber","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2026.101717_bib0021","article-title":"Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction","author":"Stephen","year":"2022","journal-title":"Cardiovascular Imaging"},{"issue":"11","key":"10.1016\/j.ajpc.2026.101717_bib0022","first-page":"1809","volume":"88","author":"Yamamoto","year":"2024","journal-title":"Off J Jpn Circ Soc"},{"issue":"16","key":"10.1016\/j.ajpc.2026.101717_bib0023","first-page":"910","article-title":"Changes in non-culprit coronary lesions with PCSK9 inhibitors: the randomised, placebo-controlled FITTER trial","volume":"21","author":"Mensink","year":"2025","journal-title":"J Eur Collab Work Group Interv Cardiol Eur Soc Cardiol"},{"issue":"4","key":"10.1016\/j.ajpc.2026.101717_bib0024","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oeae055","article-title":"Early and short-term use of proprotein convertase anti-subtilisin-kexin type 9 inhibitors on coronary plaque stability in acute coronary syndrome","volume":"4","author":"Uehara","year":"2024","journal-title":"Eur Heart J Open"},{"key":"10.1016\/j.ajpc.2026.101717_bib0025","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1161\/ATVBAHA.124.319396","article-title":"Differences in stable and unstable atherosclerotic plaque","volume":"44","author":"Kawai","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.ajpc.2026.101717_bib0026","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.atherosclerosis.2015.05.011","article-title":"Natural progression of atherosclerosis from pathologic intimal thickening to late fibroatheroma in human coronary arteries: a pathology study","volume":"241","author":"Otsuka","year":"2015","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.ajpc.2026.101717_bib0027","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jacc.2022.11.045","article-title":"Intravascular imaging during percutaneous coronary intervention: jacc state-of-the-art review","volume":"81","author":"Truesdell","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.ajpc.2026.101717_bib0028","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1056\/NEJMoa2305861","article-title":"Optical coherence tomography-guided versus angiography-guided PCI","volume":"389","author":"Ali","year":"2023","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.ajpc.2026.101717_bib0029","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1056\/NEJMoa2216607","article-title":"Intravascular imaging-guided or angiography-guided complex PCI","volume":"388","author":"Lee","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101717_bib0030","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.125.015141","article-title":"Optical coherence tomography versus angiography alone to guide PCI for complex lesions: a meta-analysis of randomized controlled trials","author":"Ezenna","year":"2025","journal-title":"Cardiovasc Interv"},{"issue":"10429","key":"10.1016\/j.ajpc.2026.101717_bib0031","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0140-6736(23)02454-6","article-title":"Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysis","volume":"403","author":"Stone","year":"2024","journal-title":"Lancet"},{"issue":"29","key":"10.1016\/j.ajpc.2026.101717_bib0032","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1093\/eurheartj\/ehad373","article-title":"Smooth muscle \u03b1-actin missense variant promotes atherosclerosis through modulation of intracellular cholesterol in smooth muscle cells","volume":"44","author":"Kaw","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2026.101717_bib0033","doi-asserted-by":"crossref","DOI":"10.1161\/STR.0000000000000475","article-title":"2024 guideline for the primary prevention of stroke: a guideline From the American heart association\/American stroke association","volume":"55","author":"Bushnell","year":"2024","journal-title":"Stroke"},{"key":"10.1016\/j.ajpc.2026.101717_bib0034","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2026.101717_bib0035","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001328","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"151","author":"Rao","year":"2025","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.ajpc.2026.101717_bib0036","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1016\/j.jacc.2017.10.024","article-title":"Normal LDL-cholesterol levels are associated with subclinical atherosclerosis in the absence of risk factors","volume":"70","author":"Fern\u00e1ndez-Friera","year":"2017","journal-title":"JACC"},{"issue":"12","key":"10.1016\/j.ajpc.2026.101717_bib0037","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101717_bib0038","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.atherosclerosis.2016.03.010","article-title":"PCSK9 in relation to coronary plaque inflammation: results of the ATHEROREMO-IVUS study","volume":"248","author":"Cheng","year":"2016","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.ajpc.2026.101717_bib0039","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jamacardio.2019.3780","article-title":"Apolipoprotein B particles and cardiovascular disease: a narrative review","volume":"4","author":"Sniderman","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ajpc.2026.101717_bib0040","article-title":"Causal relevance of LP(a) for coronary heart disease and stroke types in East Asian and European ancestry populations: a mendelian randomization study","author":"Chen","year":"2025","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101717_bib0041","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s12170-025-00760-1","article-title":"Lipoprotein(a) as a causal risk factor for cardiovascular disease","volume":"19","author":"Doherty","year":"2025","journal-title":"Curr Cardiovasc Risk Rep"},{"issue":"21","key":"10.1016\/j.ajpc.2026.101717_bib0042","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.jacc.2025.03.499","article-title":"An oral PCSK9 inhibitor for treatment of hypercholesterolemia: the PURSUIT randomized trial","volume":"85","author":"Koren","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2026.101717_bib0043","article-title":"Efficacy and safety of oral PCSK9 inhibitor enlicitide in adults with heterozygous familial hypercholesterolemia: a randomized clinical trial","author":"Ballantyne","year":"2025","journal-title":"JAMA"}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667726002928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667726002928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:19:34Z","timestamp":1790036374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666667726002928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":43,"alternative-id":["S2666667726002928"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2026.101717","relation":{},"ISSN":["2666-6677"],"issn-type":[{"value":"2666-6677","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of PCSK9 inhibitors on coronary atheroma morphology in patients with coronary artery disease treated with statins: a meta-analysis and systematic review","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2026.101717","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101717"}}